Survival curves comparing (A) event-free survival and (B) overall survival in children ages 0 to 4 years with Down syndrome treated on the Children’s Oncology Group AAML0431 trial (dark blue) vs the legacy Pediatric Oncology Group A2971 AML/MDS study (red).